Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cangrelor + Ticagrelor vs Ticagrelor in STEMI
NCT02943369Phase 4Completed
- Sponsor
- Attikon University Hospital
- Start
- Jul 2017
- Primary completion
- Nov 2017
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of cangrelor in ST-segment elevation myocardial infarction (STEMI), sponsored by Attikon University Hospital. Started Jul 2017; status: completed.
02
Drugs
cangrelor
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02943369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02943369.